Introduction of a buffer exchange and concentration device developed to accommodate biological preparations and biomolecules for gene therapy.
In the development of vectors such as LNP (lipid nanoparticles) and AAV (adeno-associated virus), buffer exchange is an important step and presents various challenges. LNP requires rapid exchange, while AAV necessitates improvements in recovery rates and concentration, so a single solution is not always optimal. Unagi is a buffer exchange and concentration device developed to accommodate biomolecules for biological formulations and gene therapies, utilizing pressure-based ultrafiltration/diafiltration (UF/DF) technology. It achieves precise buffer exchange and concentration without reducing sample recovery rates. In this webinar, you will see the final exchange values, concentration values, and analytical characteristics under various conditions for LNP and AAV. ■ Date and Time: October 30 (Monday) 14:00~ ■ Speaker: Yuji Senoo, Field Application Scientist, Unchained Labs Inc. ■ Register here: https://unchainedlabs.zoom.us/webinar/register/5816780852848/WN_WfFOAUgtQGCq0tamdhQjWg
Inquire About This Product
catalog（1）
Download All Catalogs
Company information
Unchained Labs is a company headquartered in Silicon Valley, California, that provides next-generation life science tools. - A lineup of automation devices for biopharmaceutical research, gene therapy, and organic synthesis - Founded in 2015 - Locations in California, New Jersey, Boston, the UK, Brussels, Germany, Shanghai, and Japan - Established a Japanese subsidiary in July 2017
